A multidisciplinary team at UT Southwestern Medical Center has developed an AI-enabled pipeline that can quickly and accurately extract relevant information from complex, free-text medical records. The team’s novel approach, published in npj Digital Medicine, could dramatically reduce the time needed to create analysis-ready data for research studies.
A personalized brain stimulation system powered by artificial intelligence (AI) that can safely enhance concentration from home has been developed by researchers from the University of Surrey, the University of Oxford and Cognitive Neurotechnology. Designed to adapt to individual characteristics, the system could help people improve focus during study, work, or other mentally demanding tasks
New designer proteins created using an AI tool can selectively target peptide segments that bind to markers on diseased cancer cells, acting like molecular flags that signal immune cells to attack and destroy the threats.
MIDDLETON, Wis., July 29, 2025 /PRNewswire/ — Leo Cancer Care, a leader in upright radiotherapy solutions, today announces that its flagship product, Marie®, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Simple technology that harnesses ultraviolet light to zap airborne viruses has been shown to significantly lower the number of respiratory infections in aged care facilities, paving the way for smarter infection control.
A Northeastern University researcher has identified a way to target two of the deadliest cancer types, melanoma and triple negative breast cancer, with chemotherapy drugs but without the harms associated with chemotherapy.
An international research team has developed an easy online test capable of detecting toxoplasmosis infection without a blood sample, opening the door for a better understanding of how the common parasite affects human behavior.
Reliable and gentler control of cellular activity with light: Researchers at the Cluster of Excellence Multiscale Bioimaging (MBExC) and the Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ OT) of the University Medical Center Göttingen (UMG) have developed a light-sensitive protein that can restore vision and hearing and regulate heart rhythm.
Johns Hopkins University researchers have grown a novel whole-brain organoid, complete with neural tissues and rudimentary blood vessels—an advance that could usher in a new era of research into neuropsychiatric disorders such as autism.
Dexcom (Nadsaq:DXCM) announced today that it released a new AI-powered photo meal logging feature for its Stelo platform.